Indian companies have committed a record $20.5 billion in fresh US investment. The pharmaceutical sector accounts for $19.1 billion of the total, the US embassy said on Wednesday.
Industry leaders announced the investments at a summit in Maryland. The plans cover pharmaceuticals, advanced manufacturing, energy infrastructure, and emerging technologies. Officials expect the investments to create thousands of jobs in both countries. They also aim to strengthen joint innovation and production capacity.
The embassy quoted US Ambassador Sergio Gor as saying the initiative supports the goal of doubling US–India bilateral trade to $500 billion by 2030. He said fair and mutually beneficial trade continues to attract global investment. He added that the partnership will create shared prosperity for both nations.
Pharmaceuticals Drive Investment
Indian pharmaceutical firms will invest more than $19.1 billion in US manufacturing, research, and new facilities. Sun Pharmaceutical Industries Ltd is leading the push. The company has proposed a $11.75 billion acquisition of Organon & Co., based in New Jersey.
Other participating firms include Aurobindo Pharma Ltd, Biocon Group, Cipla Ltd, Dr. Reddy’s Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Granules India Ltd, Jubilant Group, Lupin Ltd, Piramal Pharma Ltd, and Zydus Lifesciences Ltd.
These companies plan to expand manufacturing networks. They will also build new greenfield facilities and increase research and development spending. The goal is to boost the supply of essential medicines. The investments will also help address drug shortages and strengthen the US healthcare supply chain.
Additionally, 12 Indian companies announced more than $1.1 billion in new greenfield and expansion projects. These projects span multiple US states and will support jobs in manufacturing, engineering, and technology.
Also Read: Indian companies to increase hiring in 2026 over 2025
Manufacturing Sector Expands
JSW Steel confirmed plans to commission $255 million in modernisation projects. These upgrades will take place at facilities in Ohio and Texas.
Ahmedabad-based Abhyuday Group will invest over $900 million across five US sites. The company expects to create around 1,500 jobs.
Jindal Pipe and Jindal Tubular USA will invest $87 million. The expansion in Texas and Mississippi will generate 140 jobs.
Jivo Wellness will invest $15 million. The move will create 50 direct jobs and up to 150 indirect jobs. Polyhose Inc. will invest $2 million in Los Angeles to support the US shipbuilding industry.
Technology and AI Gain Ground
Sterlite Technologies Ltd will invest $100 million in AI and telecom infrastructure. The project could create up to 500 jobs.
Techdome Solutions will invest $7.5 million and create 100 jobs. RoshAi will invest $5 million in Texas. Atri AI will invest $2 million in Menlo Park, California.
Kissflow plans a $2 million investment in Houston. SatoriXR will invest $1.5 million in Michigan and create 25 jobs.
Energy and Research Expansion
MagnoInnovation Lab will invest $2 million to establish US field operations. The focus will be on energy sector applications.
The Indian Institute of Technology Madras Global Research Foundation will invest $4.5 million. It will set up a research and collaboration hub in California. The organisation also plans to expand to the East Coast.
The record commitment reflects deepening economic ties between India and the United States. Pharmaceuticals remain the main driver of this investment wave.
Also Read: Bengaluru airport rolls out AI safety system to improve operations